Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.26 EUR
783.64 M EUR
3.08 B EUR
328.10 M
About ONO PHARMACEUTICAL CO
Sector
CEO
Gyo Sagara
Headquarters
Osaka
Website
Founded
1947
ISIN
JP3197600004
FIGI
BBG000C4QB31
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ON4 is 9.95 EUR — it has decreased by −0.50% in the past 24 hours. Watch ONO PHARMACEUTICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ONO PHARMACEUTICAL CO LTD stocks are traded under the ticker ON4.
ON4 stock has fallen by −0.50% compared to the previous week, the month change is a −6.13% fall, over the last year ONO PHARMACEUTICAL CO LTD has showed a −38.96% decrease.
We've gathered analysts' opinions on ONO PHARMACEUTICAL CO LTD future price: according to them, ON4 price has a max estimate of 15.32 EUR and a min estimate of 8.58 EUR. Watch ON4 chart and read a more detailed ONO PHARMACEUTICAL CO LTD stock forecast: see what analysts think of ONO PHARMACEUTICAL CO LTD and suggest that you do with its stocks.
ON4 stock is 4.17% volatile and has beta coefficient of 0.41. Track ONO PHARMACEUTICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is ONO PHARMACEUTICAL CO LTD there?
Today ONO PHARMACEUTICAL CO LTD has the market capitalization of 4.56 B, it has decreased by −4.56% over the last week.
Yes, you can track ONO PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
ONO PHARMACEUTICAL CO LTD is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
ON4 earnings for the last quarter are 0.22 EUR per share, whereas the estimation was 0.32 EUR resulting in a −29.02% surprise. The estimated earnings for the next quarter are 0.26 EUR per share. See more details about ONO PHARMACEUTICAL CO LTD earnings.
ONO PHARMACEUTICAL CO LTD revenue for the last quarter amounts to 766.45 M EUR, despite the estimated figure of 789.55 M EUR. In the next quarter, revenue is expected to reach 801.21 M EUR.
ON4 net income for the last quarter is 105.35 M EUR, while the quarter before that showed 143.79 M EUR of net income which accounts for −26.73% change. Track more ONO PHARMACEUTICAL CO LTD financial stats to get the full picture.
ONO PHARMACEUTICAL CO LTD dividend yield was 3.26% in 2023, and payout ratio reached 30.01%. The year before the numbers were 2.53% and 30.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 3.85 K employees. See our rating of the largest employees — is ONO PHARMACEUTICAL CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ONO PHARMACEUTICAL CO LTD EBITDA is 877.30 M EUR, and current EBITDA margin is 36.15%. See more stats in ONO PHARMACEUTICAL CO LTD financial statements.
Like other stocks, ON4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONO PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ONO PHARMACEUTICAL CO LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ONO PHARMACEUTICAL CO LTD stock shows the strong sell signal. See more of ONO PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.